Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sukriti Kamboj"'
Autor:
Sven Kruspe, David D. Dickey, Kevin T. Urak, Giselle N. Blanco, Matthew J. Miller, Karen C. Clark, Elliot Burghardt, Wade R. Gutierrez, Sneha D. Phadke, Sukriti Kamboj, Timothy Ginader, Brian J. Smith, Sarah K. Grimm, James Schappet, Howard Ozer, Alexandra Thomas, James O. McNamara, II, Carlos H. Chan, Paloma H. Giangrande
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 8, Iss , Pp 542-557 (2017)
A challenge for circulating tumor cell (CTC)-based diagnostics is the development of simple and inexpensive methods that reliably detect the diverse cells that make up CTCs. CTC-derived nucleases are one category of proteins that could be exploited t
Externí odkaz:
https://doaj.org/article/0ebf681e427840ed926a8dc7f4b6acf9
Autor:
Warren W. Acker, Daniel Sporn, Abhishek Mishra, Edo Kaluski, Dwight D. Stapleton, Maninder Singh, Sukriti Kamboj
Publikováno v:
Journal of Cardiovascular Pharmacology. 74:82-90
The objective of this article is to review the contemporary literature on the use of antithrombotic therapy in patients with atrial fibrillation (AF) and coronary artery disease after undergoing percutaneous coronary intervention (PCI). Special consi
Publikováno v:
Journal of Clinical Oncology. 37:e18256-e18256
e18256 Background: In 2018, there were over 234,030 patients diagnosed with lung cancer in the US with over 154,050 deaths. While the incidence continues to fall (mostly due to reduced tobacco consumption ), the mortality continues to be high with an
Publikováno v:
Journal of Clinical Oncology. 36:6618-6618
6618Background: Invasive fungal infections (IFI) are a cause of morbidity, mortality and increased health costs in patients with Acute Leukemia (AL) and hematopoietic stem cell transplant (HSCT). W...
Publikováno v:
Chest. 152:A108
Autor:
Shilkumar Arora, Navin K. Subrayappa, Apurva Badheka, Abhishek Mishra, Harshil Shah, Sidakpal S. Panaich, Purav Shah, Sukriti Kamboj, Varun Kumar, Safi U. Khan
Publikováno v:
Chest. 152:A1047
Publikováno v:
Chest. 146:653A
Publikováno v:
Chest. 146:555A
Publikováno v:
Chest. 146:199A
Publikováno v:
Journal of Clinical Oncology. 32:113-113
113 Background: Breast cancer survivors who are on adjuvant therapy with Aromatase Inhibitors (AIs) are known to have an increased risk of osteoporosis. AIs reduce estrogen levels and cause accelerated loss of bone density. Being at high risk for ost